Fe-EDTA-BISAMIDE AND Fe-ADR-925, THE IRON-BOUND HYDROLYSIS PRODUCT OF THE CARDIOPROTECTIVE AGENT DEXRAZOXANE, CLEAVE DNA VIA THE HYDROXYL RADICAL
1997
Iron Compounds and DNA Cleavage
publication
Evidence: moderate
Author Information
Author(s): Thomas J. Magliery, Lizabeth K. Vitellaro, Ndeye Khady Diop, Rosemary A. Marusak
Primary Institution: Kenyon College
Hypothesis
Can the iron-bound hydrolysis products of dexrazoxane cleave DNA via hydroxyl radicals?
Conclusion
The study shows that Fe-ADR-925 and Fe-EDTA-bisamide can cleave DNA under certain conditions, likely through hydroxyl radicals.
Supporting Evidence
- Fe-ADR-925 and Fe-EDTA-bisamide cleaved plasmid DNA under Fenton conditions.
- DNA cleavage was inhibited by the radical scavenger thiourea.
- Fe-ADR-925 produced hydroxyl radicals similarly to Fe-EDTA.
Takeaway
This study found that certain iron compounds can cut DNA, which might explain some side effects of cancer treatments.
Methodology
The study used plasmid DNA and various iron compounds to test for DNA cleavage under Fenton conditions.
Limitations
The study does not address the long-term effects of these compounds on living organisms.
Want to read the original?
Access the complete publication on the publisher's website